Evaluating personalized circulating tumor DNA detection for early-stage lung cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Haihua,Huang ^[1] ; Zhentian,Kai ^[2] ; Yuchen,Wang ^[1] ; Xiaomiao,Zhang ^[1] ; Jin,Wang ^[1] ; Wei,Zhang ^[1] ; Qian,Xue ^[1] ; Hang,Zhang ^[1] ; Hansong,Jin ^[1] ; Peize,Meng ^[1] ; Shuilong,Zhang ^[2] ; Yueyue,Yang ^[2] ; Honghua,Yang ^[2] ; Wanning,Liang ^[2] ; Guangbing,Zha ^[2] ; Peng,Luo ^[2] ; Yan,Xu ^[2] ; Weiwei,Shi ^[2] ; Zheng,Ruan ^[1]

作者单位： Department of Thoracic Surgery, Shanghai First People's Hospital, Shanghai, China. ^[1] Department of research and Development, Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., Shanghai, China. ^[2]

关键词 biomarkers biotechnology genomics lung cancer molecular diagnosis

主题词人类(Humans);肺肿瘤(Lung Neoplasms);女(雌)性(Female);支气管肺泡灌洗液(Bronchoalveolar Lavage Fluid);男(雄)性(Male);肿瘤分期(Neoplasm Staging);癌症早期检测(Early Detection of Cancer);中年人(Middle Aged);老年人(Aged)

DOI 10.1002/cam4.6817

PMID 38112031

发布时间 2024-05-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer medicine

2024年13卷10期

e6817页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluating personalized circulating tumor DNA detection for early-stage lung cancer.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluating personalized circulating tumor DNA detection for early-stage lung cancer.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除